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The objective of this research was to quantify the 
specific weight of maternal mortality in Sub-Saharan 
African and to determine the healthcare, cultural and 
economic factors involved in this.
UDK: 616.24-085.322
Ekta Rani
AYURVEDIC WAYS TO TREAT LUNG DISORDERS
Indian herbal medicine also known as Ayurvedic 
medicine and is the oldest organized system of medicine. 
Today we classify it as a complementary and alternative 
medicine but to Indians is known as the divine medicine 
due to its long history. Ayurvedic is grounded in the 
understanding that the universe and the body are 
composed of five great elements: Earth, Water, Fire, Air 
and Ether. Additionally Ayurveda stresses the importance 
of balance through three elemental energies. Everyone 
possesses these energies or doshas as they are known. 
These doshas are important because when they are 
balanced within the body, then you are healthy, but when 
they become imbalanced the body possesses diseases. 
Curcumin – substance found in turmeric is an 
antioxidant that prevents inflammation. Thus helps 
it to prevent the growth of cancer cells, as well as kill 
the existing cancer cells. Gynostemma pentaphyllum 
– specifically it prevents the growth of cancer cells and 
increases immunity. Arjuna – Extract of Terminalia 
Arjuna tree bark that helps with lung cancer. The 
flavanoids present in the Arjuna bark have high anti-
oxidant properties that kills the cancerous cells. 
Ashwagandha (Indian Ginseng) – rich in flavanoids, 
the anti-inflammatory, antioxidant, antitumor properties 
help prevent spread of cancer as well as kill cancer cells 
to cure lung cancer. Shatavari (Asparagus) — this is 
rejuvenating and is used to strengthen the patient after 
standard treatments like chemotherapy. 
The Ayurvedic treatment of chronic obstructive 
pulmonary disease is aimed at relieving the symptoms, 
slowing down the progress of the disease, improving 
exercise tolerance, preventing and treating complications 
and improving overall health. Medicines like Sitopaladi-
Churna, Talisadi-Churna, Yashtimadhuk (Glycerrhiza 
glabra), Tulsi (Ocimum sanctum), Pippali (Piper 
longum), Som (Ephedra vulgaris) Kantakari (Solanum 
xanthocarpum), Kushtha (Alpimia galangal), Vasa 
(Adhatoda vasaka) and Behada (Terminalia bellerica) 
are used to reduce cough and breathlessness. Medicines 
which act on the ‘Rakta’ dhatu (tissue) are useful in this 
condition. These include Patol (Tricosanthe dioica), Kutki 
(Picrorrhiza kurroa), Saariva (Hemidesmus indicus), 
Patha (Cissampelos pareira), Musta (Cyperus rotundus), 
Triphala (Three fruits) and Nimba (Azadirachta indica).
Common conditions that have found relief through 
herbal remedies include angina, arthritis, skin care, 
thyroid, urinary tract infections and many more. New 
products are coming out that help for additional problems 
such as smoking cessation, removing unwanted hair, and 
eliminating wrinkles.
Material and methods. We studied 38 patients with 
type 2 diabetes (42% men and 58% women, mean 
age – 56,0±1,36 years, average duration of DM – 
8,0±0,79 years), hospitalized to Chernivtsi Regional 
Endocrinological Center during a month period. In 29% 
of participating patients the duration of diabetes was less 
than 5 years, in 40% – 5-10 years, 31% of patients had 
diabetes longer than 10 years. Fasting and postprandial 
glucose concentration, lipids level, AST and ALT were 
measured in plasma using standard clinical methods. 
Establishment of MS diagnosis was based on the presence 
of central obesity, defined as waist circumference more 
than 102/88 cm for men/women plus any two of the 
following four factors: raised triglycerides ≥150 mg/dl 
(1,7 mmol/l), reduced HDL cholesterol <40 mg/dL (1,0 
mmol/l) for men and < 50 mg/dL (1,3 mmol/l) for women, 
raised blood pressure ≥ 130/85 mmHg, raised fasting 
hyperglycemia >110 mg/dl (6,0 mmol/l) or previously 
diagnosed type 2 diabetes.
Results. According to the obtained findings, normal 
body weight was observed only in 8% of patients, 
whereas in 40% of them overweight was diagnosed, in 
34% – obesity of I degree, in 13% – II degree, in 5% – 
ІІІ degree correspondingly, accompanied by abdominal 
obesity. These results are indicative of a considerable risk 
to develop insulin resistance and metabolic disturbances 
in the examined patients. ALT and AST were steadily 
elevated according to the increase of BMI and waist 
circumference. Being associated with such abnormalities 
of the metabolic syndrome, as obesity, hyperglycemia 
and dyslipidemia, reflecting liver fat content, liver 
markers may indicate the worsening of hepatic glucose 
output (hepatic insulin resistance). As inexpensive and 
routinely measured clinical variables, ALT and AST are 
available for identification of insulin sensitivity without 
measurement of insulin concentrations, displaying a 
satisfactory predictive capability for MS in patients with 
type 2 diabetes. 
Conclusion. Abnormal liver enzymes were associated 
with markers of MS and strongly indicate existing 
metabolic risk in patients with type 2 diabetics with 
insulin resistance. 
Bucovinian State Medical University, Chernivtsy, Ukraine
(scientific adviser -  as. prof. N.M. Malkovych)
Department of propaedeutics of internal medicine
